Insights from 2023 ASCO® Annual Meeting
Playback speed
10 seconds
ASCO® 2023 Insights: "TROPiCS-02 Phase 3 Study Final OS Analysis - Sacituzumab Govitecan in Pts With HR+/HER2- mBC"
By
Insights from 2023 ASCO® Annual Meeting
FEATURING
Sara Tolaney
By
Insights from 2023 ASCO® Annual Meeting
FEATURING
Sara Tolaney
705 views
June 7, 2023
Comments 0
Login to view comments.
Click here to Login
Breast